-
Is Immunotherapy Right for People Hospitalized With Advanced Cancer?
Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.
by Kyle Bagenstose
-
Researchers Tackle Immune-related Adverse Effects
Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
-
Immunotherapy Improves Results in Head and Neck Cancer
Combining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
-
Forward Look
Controlling Cancer Without SurgeryImmunotherapy can induce a complete response in some people with mismatch repair-deficient cancers.
by Thomas Celona
-
Injection Immunotherapies Get FDA Approval
Giving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
-
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung Cancer
The drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore
-
Vaccines Spark Activity in Pancreatic Cancer
Scientists thought pancreatic cancer wouldn’t respond to immunotherapy. Now research has found vaccines can trigger the immune system to fight the disease.
by Thomas Celona
-
TIL Therapy Amplifies the Immune System’s Attack on Melanoma
The recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
by Sandra Gordon
-
Light at the End of the Tunnel for ASPS Patients
Immunotherapy has helped some young people with alveolar soft part sarcoma (ASPS), a rare cancer, but there’s more work to be done.
by Kyle Bagenstose
-
CAR T-cell Therapy: Understanding the Warning and the Risks
The FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?
by Sandra Gordon
Cancer Talk
Physical Activity Linked to Lower Colon Cancer Recurrence
Participating in a structured exercise program after treatment was associated with a reduced risk of recurrence in people who had colon cancer.
by Sandra Gordon
Gaps in Survivorship Care Leave Unmet Needs After Cancer TreatmentA survey of head and neck cancer survivors reveals that many are not getting adequate survivorship care and may not even know it is available.
by Cameron Walker
Improving Communication for Deaf Cancer PatientsAfter a cancer diagnosis, people who are deaf or have hearing problems can struggle if accommodations don’t meet their communication needs.
by Eric Fitzsimmons
Is Immunotherapy Right for People Hospitalized With Advanced Cancer?Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.
by Kyle Bagenstose